Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marja-Riitta Taskinen

Showing results (71-80 of 230) with videos related to

Pageof 23
Sort By:
European Heart Journal|June 26, 2023
Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank studyElias Björnson, Martin Adiels, Marja-Riitta Taskinen, et al.
Obesity (Silver Spring, Md.)|July 9, 2009
HDL subspecies in young adult twins: heritability and impact of overweightKirsi H Pietiläinen, Sanni Söderlund, Aila Rissanen, et al.
Obesity (Silver Spring, Md.)|June 4, 2014
Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride-rich lipoproteinsNiina Matikainen, Martin Adiels, Sanni Söderlund, et al.
Diabetes, Obesity & Metabolism|August 4, 2018
Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled studyNiina Matikainen, Sanni Söderlund, Elias Björnson, et al.
Molecular Biosystems|June 23, 2012
Metabolomic analysis of polar metabolites in lipoprotein fractions identifies lipoprotein-specific metabolic profiles and their association with insulin resistanceTuulia Hyötyläinen, Ismo Mattila, Susanne K Wiedmer, et al.
Journal of the American College of Cardiology|January 17, 2024
Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic AnalysisElias Björnson, Martin Adiels, Marja-Riitta Taskinen, et al.
Circulation|April 1, 2003
Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS)Juha Vakkilainen, George Steiner, Jean-Claude Ansquer, et al.
Atherosclerosis|February 28, 2012
Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacityMartin Adiels, Niina Matikainen, Jukka Westerbacka, et al.
Journal of Lipid Research|March 22, 2002
LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteinsJuha Vakkilainen, Matti Jauhiainen, Kati Ylitalo, et al.
Diabetes|October 29, 2002
Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetesHelen M Colhoun, Marja-Riitta Taskinen, James D Otvos, et al.
Pageof 23

Showing results (71-80 of 230) with videos related to

Sort By:
Pageof 23
European Heart Journal|June 26, 2023
Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank studyElias Björnson, Martin Adiels, Marja-Riitta Taskinen, et al.
Obesity (Silver Spring, Md.)|July 9, 2009
HDL subspecies in young adult twins: heritability and impact of overweightKirsi H Pietiläinen, Sanni Söderlund, Aila Rissanen, et al.
Obesity (Silver Spring, Md.)|June 4, 2014
Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride-rich lipoproteinsNiina Matikainen, Martin Adiels, Sanni Söderlund, et al.
Diabetes, Obesity & Metabolism|August 4, 2018
Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled studyNiina Matikainen, Sanni Söderlund, Elias Björnson, et al.
Molecular Biosystems|June 23, 2012
Metabolomic analysis of polar metabolites in lipoprotein fractions identifies lipoprotein-specific metabolic profiles and their association with insulin resistanceTuulia Hyötyläinen, Ismo Mattila, Susanne K Wiedmer, et al.
Journal of the American College of Cardiology|January 17, 2024
Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic AnalysisElias Björnson, Martin Adiels, Marja-Riitta Taskinen, et al.
Circulation|April 1, 2003
Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS)Juha Vakkilainen, George Steiner, Jean-Claude Ansquer, et al.
Atherosclerosis|February 28, 2012
Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacityMartin Adiels, Niina Matikainen, Jukka Westerbacka, et al.
Journal of Lipid Research|March 22, 2002
LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteinsJuha Vakkilainen, Matti Jauhiainen, Kati Ylitalo, et al.
Diabetes|October 29, 2002
Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetesHelen M Colhoun, Marja-Riitta Taskinen, James D Otvos, et al.
Pageof 23